PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

160 hedge funds and large institutions have $873M invested in Pacific Biosciences in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 41 reducing their positions, and 23 closing their positions.

Holders
160
Holders Change
+5
Holders Change %
+3.23%
% of All Funds
3.47%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
29
Increased
65
Reduced
41
Closed
23
Calls
$1.19M
Puts
$4.36M
Net Calls
-$3.17M
Net Calls Change
-$7.29M

Top Buyers

1
UOC
1
UBS O'Connor
Illinois
$43.8M
2
Citadel Advisors
2
Citadel Advisors
Florida
$19.1M
3
KLCMU
3
Kite Lake Capital Management (UK)
United Kingdom
$18.7M
4
WIC
4
Water Island Capital
New York
$26.2M
5
VI
5
Versor Investments
New York
$22.5M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$14.1M
3
Capital International Investors
3
Capital International Investors
California
$0
4
OIM
4
Oracle Investment Management
Connecticut
$8.03M
5
MF
5
Magnetar Financial
Illinois
$59.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
MWNA
176
Marshall Wace North America
New York
– -$94K -12,658 Closed
Simplex Trading
177
Simplex Trading
Illinois
– -$59K -8,045 Closed
ER
178
Enlightenment Research
Florida
– -$17K -2,300 Closed
MTCM
179
Mint Tower Capital Management
Netherlands
– -$5K -700 Closed
AIM
180
ARK Investment Management
Florida
– -$4K -590 Closed
PA
181
Perennial Advisors
New York
– -$1K -100 Closed
4 5 6 7
8